Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study.

Antonella Marino Gammazza, Dragana Nikolic, Manfredi Rizzo, Giuseppe Montalto, Rosaria Vincenza Giglio, Esma R. Isenovic, Antonella Marino Gammazza, Maciej Banach, Ignazio Barbagallo, Manfredi Rizzo, Manisha Chandalia, Giovanni Li Volti, Nicola Abate, Ali A. Rizvi, Manfredi Rizzo

Risultato della ricerca: Articlepeer review

63 Citazioni (Scopus)

Abstract

Context: Liraglutide is a glucagon-like peptide-1 analog and glucose-lowering agent whose effects on cardiovascular risk markers have not been fully elucidated.Objective: We evaluated the impact of liraglutide on markers of oxidative stress, heme oxygenase-1 (HO-1), and plasma ghrelin levels in patients with type-2 diabetes (T2DM).Design and setting: A prospective pilot study of two months’ duration performed at the Unit of Diabetes and Cardiovascular Prevention at University of Palermo, Italy. Patients and Intervention(s): 20 subjects with T2DM (10 men and 10 women, mean age: 57±13 years) were treated with liraglutide subcutaneously (0.6mg/daily for 2 weeks, followed by 1.2mg/daily) in addition to metformin (1500 mg/daily orally) for 2 months. Patients with liver disorders or renal failure were excluded.Main Outcome Measure(s): Plasma ghrelin concentrations, oxidative stress markers, and heat-shock proteins, including HO-1.Results: The addition of liraglutide resulted in a significant decrease in glycated hemoglobin (HbA1c) (8.5±0.4 vs. 7.5±0.4%, p<0.0001). In addition, plasma ghrelin and glutathione (GSH) concentrations increased (8.2±4.1 vs. 13.6±7.3 pg/ml, p=0.0007 and 0.36±0.06 vs. 0.44±0.07 nmol/ml, p=0.0002, respectively), while serum lipid hydroperoxides and HO-1 decreased (0.11±0.05 vs. 0.04±0.07 pg/ml, p=0.0487 and 7.7±7.7 vs. 3.6±1.8 pg/ml, p=0.0445, respectively). These changes were not correlated with changes in fasting glycemia or HbA1c.Conclusions: In a 2-months prospective pilot study, the addition of liraglutide to metformin resulted in improvement in oxidative stress as well as plasma ghrelin and HO-1 concentrations in patients with T2DM. These findings appeared to be independent of the known effects of liraglutide on glucose metabolism.
Lingua originaleEnglish
pagine (da-a)603-606
Numero di pagine4
RivistaTHE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Volumejc20142291
Stato di pubblicazionePublished - 2015

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Entra nei temi di ricerca di 'Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study.'. Insieme formano una fingerprint unica.

Cita questo